We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current 1BMY market cap is 111.04B. The company's latest EPS is USD -4.4094 and P/E is -13.52.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 42.52B | 46.39B | 46.16B | 45.01B | 48.3B |
| Operating Income | 3.12B | 7.87B | 7.24B | 6.91B | -8.49B |
| Net Income | -9.02B | 6.99B | 6.33B | 8.03B | -8.95B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 118.48B | 109.31B | 96.82B | 95.16B | 92.6B |
| Total Liabilities | 80.6B | 73.31B | 65.7B | 65.67B | 76.22B |
| Total Equity | 37.88B | 36.01B | 31.12B | 29.49B | 16.39B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 14.05B | 16.21B | 13.07B | 13.86B | 15.19B |
| Investing | -10.86B | -538M | -1.06B | -2.3B | -21.35B |
| Financing | -1.15B | -16.22B | -16.96B | -9.42B | 5.13B |
| Market Cap | 111.04B |
| Price to Earnings Ratio | -13.52 |
| Price to Sales Ratio | 2.5 |
| Price to Cash Ratio | 11.69 |
| Price to Book Ratio | 7.38 |
| Dividend Yield | 4.72% |
| Shares Outstanding | 2.03B |
| Average Volume (1 week) | 127 |
| Average Volume (1 Month) | 180 |
| 52 Week Change | 16.18% |
| 52 Week High | 60.00 |
| 52 Week Low | 36.00 |
| Spread (Intraday) | 1.75 (3.1%) |
| Company Name | Bristol Myers Squibb |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.bms.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
